SEARCH

    Saved articles

    You have not yet added any article to your bookmarks!

    Browse articles
    Select News Languages

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policies, and Terms of Service.

    newshunt
    newshunt

    Bryan Johnson Considers Taking A Step Back From Anti-Ageing Venture, Calls It 'A Pain In The..'

    1 week ago

    Bryan Johnson, the 47-year-old biotech entrepreneur known for his extensive anti-ageing routine, has indicated that he may either sell or close his wellness startup, Blueprint.

    In an interview with Wired, Johnson referred to the business as a "pain-in-the-ass company" and said he has initiated conversations about stepping away from it.

    “Honestly, I am so close to either shutting it down or selling it,” he told Wired. “I don't need the money, and it's a pain-in-the-ass company.”

    Founded as part of Johnson’s longevity initiative, Project Blueprint, the company markets a range of health and wellness products, including a “longevity mix” drink priced at Rs 4,700 and a mushroom-based coffee alternative, Super Shrooms, priced at Rs 3,600. Johnson has previously said the personal anti-ageing programme he follows costs around $2 million (over Rs 17 crore) annually.

    Johnson recently announced the formation of a new religion called “Don’t Die”, and has stated that he is increasingly focused on philosophical and personal pursuits, reported Moneycontrol. According to him, the company was originally created to meet requests from friends who were interested in his supplements, but he now believes continuing to operate Blueprint detracts from his credibility in non-commercial areas.

    “It evolved in a way where I was trying to do people a solid,” Johnson said. “People see the business and give me less credibility on the philosophy side. I will not make that trade-off. It is not worth it to me. So yeah, I don’t want it.”

    Also Read : Tariff Tensions Escalate: India–US Interim Deal Unlikely Before Deadline, Says Report

    'Blueprint' Under Financial Scanner

    Notably, earlier this year, The New York Times reported that Blueprint had not met its break-even point and was missing its target by at least $1 million per month, citing court records, interviews, and internal documents. While Johnson did not comment on the company's financials at the time, he has since stated that Blueprint is not under financial duress.

    “We are break-even, and I’ve said that publicly many times,” he told Wired. “We’ve had profitable months, we’ve had loss months.”

    There is currently no official confirmation regarding the sale or closure of Blueprint. Johnson has not disclosed details of potential buyers or a specific timeline for any decision.

    Click here to Read more
    Prev Article
    Gurugram’s Never-Ending Civic Nightmare: French Expat Calls City ‘A Massive Landfield’
    Next Article
    Viral Video Of Obscene Dance During Kanwar Yatra Sparks Outrage

    Related Trending Updates:

    Comments (0)

      Leave a Comment